Reaction
Graft Versus Host Disease In Eye reporting signals
As of the last recalculation, Graft Versus Host Disease In Eye appears in 228 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is FLUDARABINE PHOSPHATE (PRR 144.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fludarabine Phosphate | 49 | 144.6 | 144.8 |
| Busulfan | 19 | 120.2 | 120.3 |
| Thiotepa | 11 | 110.4 | 110.6 |
| Sirolimus | 14 | 101.0 | 101.1 |
| Bosutinib | 8 | 84.2 | 84.3 |
| Blinatumomab | 9 | 81.9 | 82.0 |
| Imatinib | 14 | 77.1 | 77.2 |
| Posaconazole Delayed-Release | 6 | 51.2 | 51.2 |
| Ruxolitinib | 34 | 50.7 | 50.8 |
| Dasatinib | 13 | 33.8 | 33.8 |
| Lifitegrast | 3 | 17.0 | 17.0 |